BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2021 8:44:04 AM | Browse: 614 | Download: 1679
 |
Received |
|
2021-03-22 06:12 |
|
Peer-Review Started |
|
2021-03-22 06:19 |
|
First Decision by Editorial Office Director |
|
2021-07-05 09:47 |
|
Return for Revision |
|
2021-07-05 09:47 |
|
Revised |
|
2021-07-13 12:37 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-13 02:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-13 03:33 |
|
Articles in Press |
|
2021-08-13 03:33 |
|
Edit the Manuscript by Language Editor |
|
2021-09-09 03:32 |
|
Typeset the Manuscript |
|
2021-10-18 00:58 |
|
Publish the Manuscript Online |
|
2021-10-21 08:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Long-term survival of a patient with pancreatic cancer and lung metastasis with rare gene alterations after resection and apatinib therapy: a case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Wei Yang, Lin Yang, Hai-Zhen Lu and Yong-Kun Sun |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Wu Jieping Medical Foundation |
320.6750.2020-10-95 |
| Sanming Project of Medicine in Shenzhen |
SZSM202011010 |
|
| Corresponding Author |
Yong-Kun Sun, MD, Professor, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. hsunyk@cicams.ac.cn |
| Key Words |
Pancreatic cancer; BAP1 mutation; PIK3CA mutation; Raf1 fusion; Apatinib; Case report |
| Core Tip |
We reported that a patient with pancreatic ductal adenocarcinoma (PDAC) possessing exceptionally rare RAF1, BAP1 and PIK3CA gene alterations achieved partial responses to apatinib combination therapy twice and experienced long-term survival. Until now, there have been no reports of a long-term PDAC patient with RAF1, BAP1 and PIK3CA aberrations who did not also have K-Ras, TP53, p16/CDKN2A, or SMAD4 gene alterations. In such a rare case, we presume that PDAC with this special genetic alteration pattern may be converted to a kind of “indolent cancer”, which presents fewer symptoms and indicates a good prognosis for pancreatic cancer patients. |
| Publish Date |
2021-10-21 08:44 |
| Citation |
Yang WW, Yang L, Lu HZ, Sun YK. Long-term survival of a patient with pancreatic cancer and lung metastasis: A case report and review of literature. World J Clin Cases 2021; 9(30): 9134-9143 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i30/9134.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i30.9134 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
